<DOC>
	<DOCNO>NCT01944098</DOCNO>
	<brief_summary>The primary objective ass feasibility safety administer continuous intraoperative lidocaine infusion adult patient undergo laparoscopic Roux en Y Gastric Bypass ( RYGB ) . The secondary objective determine lidocaine administration versus placebo ( dextrose administration ) ( initiated time anesthesia induction continue extubation ) reduce postoperative narcotic requirement .</brief_summary>
	<brief_title>Intraoperative Lidocaine Infusion Postoperative Pain Management Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Adult patient age 1865 year old BMI ≥ 40 kg/m2 , ≤ 60 kg/m2 Undergoing primary laparoscopic RYGB Dr. Murr Agree follow 24 hour postoperatively Normal K+ Mg++ serum level BMI le 40 kg/m2 , &gt; 60 kg/m2 Laparoscopic RYGB surgery perform surgeon Dr. Murr Allergy lidocaine Allergy hydromorphone ketorolac Allergy corn amide anesthetic Use ( thioridizine ) Pregnancy Abnormalities ALT AST Intraoperative diagnosis cirrhosis portal hypertension Intraoperative complication per surgeon Intraoperative extensive adhesion per surgeon Chronic pain syndrome chronic use narcotic Severe back pain secondary degenerative joint disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>